SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-021251
Filing Date
2013-03-15
Accepted
2013-03-15 16:15:20
Documents
5
Period of Report
2013-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-7681_18k.htm 8-K 55806
2 EX-10.1 a13-7681_1ex10d1.htm EX-10.1 108101
3 EX-99.1 a13-7681_1ex99d1.htm EX-99.1 24356
4 GRAPHIC g76811mmi001.jpg GRAPHIC 5642
5 GRAPHIC g76811mmi002.jpg GRAPHIC 4935
  Complete submission text file 0001104659-13-021251.txt   204549
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 13694294
SIC: 2836 Biological Products, (No Diagnostic Substances)